Drugs of Abuse and Beyond
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Biomedical Engineering".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 49
Special Issue Editor
Interests: antibacterials; antifungals; antitumor agents; medicinal chemistry; toxicology; small molecules; antimyotonic agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Drug abuse is a worldwide issue with significative direct or indirect adverse impacts on human health and social welfare. In addition, the potential association between childhood cancer risk and maternal prenatal substance use/abuse still remains uncertain; a relationship between drug abuse and the severity of tibial shaft fractures is also under study. Finally, drugs of abuse, as well as their metabolites, represent a group of emerging pollutants in treated wastewater, surface water, drinking water, or atmosphere.
The aim of this Special Issue is to publish a set of papers that characterize the best original articles, including in-depth reviews of the state of the art and original and very up-to-date contributions that involve drugs of abuse.
Topics of interest include, but are not limited to, the following: pharmacokinetics; toxicity; metabolites; compounds detected in biological samples and their characteristics; extraction methods and analytical tools available for their detection; drug/alcohol consumption; association between use/abuse of drugs and cancer and/or fractures; and the impact of the COVID-19 pandemic on drug abuse patterns. I hope to receive a wide range of submissions and to collect relevant papers focusing on drugs of abuse and that these articles will be widely read and have a great influence in the field.
Dr. Alessia Catalano
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug abuse
- pharmacokinetics
- toxicity
- metabolites
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
